XML 21 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2021
Jun. 30, 2020
Current assets    
Cash and cash equivalents $ 492 $ 871
Receivables, net 643 648
Inventories, net 688 454
Prepaid expenses and other current assets 139 47
Total current assets 1,962 2,020
Property, plant and equipment, net of accumulated depreciation and amortization of $2,351 and $2,224, respectively 1,251 1,103
Operating lease right-of-use assets 328 291
Goodwill 1,574 1,577
Trademarks, net 694 785
Other intangible assets, net 246 109
Other assets 386 328
Total assets 6,441 6,213
Current liabilities    
Current maturities of long-term debt 300 0
Current operating lease liabilities 74 64
Accounts payable and accrued liabilities 1,445 1,329
Income taxes payable 0 25
Total current liabilities 1,819 1,418
Long-term debt 2,483 2,780
Long-term operating lease liabilities 305 278
Other liabilities 819 767
Deferred income taxes 77 62
Total liabilities 5,503 5,305
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 and 158,741,461 shares issued as of March 31, 2021 and June 30, 2020, respectively; and 124,359,712 and 126,198,606 shares outstanding as of March 31, 2021 and June 30, 2020, respectively 131 159
Additional paid-in capital 1,190 1,137
Retained earnings 1,086 3,567
Treasury stock, at cost: 6,381,749 and 32,542,855 shares as of March 31, 2021 and June 30, 2020, respectively (1,111) (3,315)
Accumulated other comprehensive net (loss) income (553) (640)
Total Clorox stockholders’ equity 743 908
Noncontrolling interests 195 0
Total stockholders’ equity 938 908
Total liabilities and stockholders’ equity $ 6,441 $ 6,213